Q4 2025 DarioHealth Corp Earnings Call Transcript
Key Points
- DarioHealth Corp (DRIO) signed 85 new agreements in 2025, more than doubling their target of 40, indicating strong business growth.
- The company achieved sequential revenue growth in the fourth quarter of 2025, marking a positive turnaround.
- DarioHealth Corp (DRIO) has expanded its commercial pipeline to $122 million, providing strong revenue visibility for future growth.
- The company has access to over 160 million covered lives through its distribution ecosystem, significantly expanding its reach.
- DarioHealth Corp (DRIO) has maintained approximately 80% non-GAAP gross margins for its core B2B2C business, showcasing strong unit economics.
- Annual revenue declined due to a single legacy client not renewing their contract, impacting overall financial performance.
- The company does not provide formal guidance, which may create uncertainty for investors regarding future financial performance.
- DarioHealth Corp (DRIO) is targeting cash flow breakeven by mid-2027, indicating a longer timeline to profitability.
- The company faces challenges in adapting its operations to accommodate large-scale partnerships, which may impact efficiency.
- There is a risk of over-reliance on a few large contracts, which could affect financial stability if these contracts do not materialize as expected.
Good morning ladies and gentlemen, and welcome to the Dario Health Fourth quarter and year-end 2025 results conference call. At this time, all lines are in listen-only mode. Following the presentation, we will conduct a question-and-answer session. If at any time during this call you require immediate assistance, please press 0 for the operator. This call is being recorded on Thursday, March 19, 2026. I would now like to turn the conference over to Zoey Harrison, VP Accounting and corporate Development at Dario Health. Zoey, please go ahead.
Thank you operator, and good morning everyone.
Thank you for joining us today for a discussion of Dario Health 4th quarter and GN 2025 financial results. Leading the call today will be Eras Rafael, Chief Executive Officer of Dario Health. He'll be joined by our President and Chief Commercial Officer, Stephen Nelson, and Hen Franco, our Chief Financial Officer.
An audio recording and webcast replay for today's call will
| Access to All Earning Calls and Stock Analysis | |
| 30-Year Financial on one screen | |
| All-in-one Stock Screener with unlimited filters | |
| Customizable Stock Dashboard | |
| Real Time Insider Trading Transactions | |
| 8,000+ Institutional investors’ 13F holdings | |
| Powerful Excel Add-in and Google sheets Add-on | |
| All data downloadable | |
| Quick customer support | |
| And much more... |
Trustpilot
We'd love to learn more about your experiences on GuruFocus.com and how we can improve!
Take Survey
